abstract |
(57) [Summary] In particular, 3S- [3R * (1R * , 2S * )]-[3-[[(4-aminophenyl) sulfonyl] (2-methylpropyl) -amino] -2-hydroxy-1-. Pharmaceutical formulations containing HIV protease inhibitors and tocophenol, including phenylmethyl) propyl] carbamic acid, tetrahydro-3-furanyl ester (also known as VX478 or 141W94), and their use in medical therapy Use is disclosed. |